{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:33:07Z","timestamp":1769574787709,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jvoice.2020.04.037","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T17:17:57Z","timestamp":1592241477000},"page":"272-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection"],"prefix":"10.1016","volume":"36","author":[{"given":"Amy","family":"Rutt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen D.","family":"Kennelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhon F.","family":"Martinez-Paredes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jvoice.2020.04.037_bib0001","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jvoice.2014.08.011","article-title":"Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients","volume":"29","author":"Rosow","year":"2015","journal-title":"J Voice"},{"issue":"11","key":"10.1016\/j.jvoice.2020.04.037_bib0002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0003489415588557","article-title":"The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients","volume":"124","author":"Patel","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"10.1016\/j.jvoice.2020.04.037_bib0003","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MLG.0b013e31815e8be0","article-title":"Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results","volume":"118","author":"Paniello","year":"2008","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.jvoice.2020.04.037_bib0004","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/lary.21872","article-title":"Coprevalence of tremor with spasmodic dysphonia: a case-control study","volume":"121","author":"White","year":"2011","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.jvoice.2020.04.037_bib0005","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/cercor\/bhq023","article-title":"Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study","volume":"20","author":"Simonyan","year":"2010","journal-title":"Cereb Cortex"},{"issue":"1","key":"10.1016\/j.jvoice.2020.04.037_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0196-0709(84)80015-0","article-title":"Spastic dysphonia: a patient profile of 200 cases","volume":"5","author":"Izdebski","year":"1984","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"10.1016\/j.jvoice.2020.04.037_bib0007","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005537-200202000-00004","article-title":"Risk factors and demographics in patients with spasmodic dysphonia","volume":"112","author":"Schweinfurth","year":"2002","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.jvoice.2020.04.037_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/000348949110000201","article-title":"Laryngeal dystonia: a series with botulinum toxin therapy","volume":"100","author":"Blitzer","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"11","key":"10.1016\/j.jvoice.2020.04.037_bib0009","first-page":"1300","article-title":"Botulinum toxin (BOTOX) for the treatment of \"spastic dysphonia\" as part of a trial of toxin injections for the treatment of other cranial dystonias","volume":"96","author":"Blitzer","year":"1986","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.jvoice.2020.04.037_bib0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lary.21395","article-title":"Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes","volume":"121","author":"Novakovic","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2020.04.037_bib0011","unstructured":"AAO-HNS. Position Statement: Botulinum Toxin Treatment. American Academy of Otolaryngology-Head and Neck Surgery. https:\/\/www.entnet.org\/content\/botulinum-toxin-treatment. Published 2017. Updated 3\/12\/2017. Accessed October 29, 2019."},{"issue":"12","key":"10.1016\/j.jvoice.2020.04.037_bib0012","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/000348940711601204","article-title":"Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia","volume":"116","author":"Holden","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"10.1016\/j.jvoice.2020.04.037_bib0013","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jvoice.2013.10.024","article-title":"Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues","volume":"28","author":"Young","year":"2014","journal-title":"J Voice"},{"issue":"5","key":"10.1016\/j.jvoice.2020.04.037_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.63.5.688","article-title":"Female predominance in spasmodic dysphonia","volume":"63","author":"ADLER","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jvoice.2020.04.037_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-1331.2010.03047.x","article-title":"Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series","volume":"17","author":"Blitzer","year":"2010","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.jvoice.2020.04.037_bib0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0967-5868(03)00020-1","article-title":"Spasmodic dysphonia: clinical features and effects of botulinum toxin therapy in 169 patients-an Australian experience","volume":"10","author":"Tisch","year":"2003","journal-title":"J Clin Neurosci"},{"issue":"10","key":"10.1016\/j.jvoice.2020.04.037_bib0017","doi-asserted-by":"crossref","first-page":"606","DOI":"10.11622\/smedj.2016112","article-title":"Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines","volume":"58","author":"Lim","year":"2017","journal-title":"Singapore Med J"},{"issue":"Suppl 1","key":"10.1016\/j.jvoice.2020.04.037_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/17429590701523752","article-title":"Patient-reported outcomes with botulinum neurotoxin type A","volume":"9","author":"Carruthers","year":"2007","journal-title":"J Cosmet Laser Ther"},{"issue":"11","key":"10.1016\/j.jvoice.2020.04.037_bib0019","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jamadermatol.2015.2232","article-title":"Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial","volume":"151","author":"Alam","year":"2015","journal-title":"JAMA dermatology"},{"issue":"12","key":"10.1016\/j.jvoice.2020.04.037_bib0020","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/DSS.0000000000001242","article-title":"YouTube Videos on Botulinum Toxin A for Wrinkles: A Useful Resource for Patient Education","volume":"43","author":"Wong","year":"2017","journal-title":"Dermatol Surg"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199720301752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199720301752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:38:22Z","timestamp":1760211502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199720301752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0892199720301752"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2020.04.037","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Experience Contributing to Outcomes of Laryngeal Botulinum Toxin Injection","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2020.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}